טוען...
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms
The therapeutic potential of arsenic derivatives has long been recognized and was recently rediscovered in modern literature. Early studies demonstrated impressive activity of this compound in patients with relapsed acute promyelocytic leukemia (APL). Over the last 2 decades intravenous arsenic trio...
שמור ב:
| הוצא לאור ב: | Cancer |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042140/ https://ncbi.nlm.nih.gov/pubmed/26716387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29852 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|